Your browser doesn't support javascript.
loading
Diffusing alpha-emitters radiation therapy in combination with temozolomide or bevacizumab in human glioblastoma multiforme xenografts.
Nishri, Yossi; Vatarescu, Maayan; Luz, Ishai; Epstein, Lior; Dumancic, Mirta; Del Mare, Sara; Shai, Amit; Schmidt, Michael; Deutsch, Lisa; Den, Robert B; Kelson, Itzhak; Keisari, Yona; Arazi, Lior; Cooks, Tomer; Domankevich, Vered.
Afiliación
  • Nishri Y; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel.
  • Vatarescu M; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel.
  • Luz I; The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, Israel.
  • Epstein L; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel.
  • Dumancic M; The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, Israel.
  • Del Mare S; Unit of Nuclear Engineering, Faculty of Engineering Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Shai A; Radiation Protection Department, Soreq Nuclear Research Center, Yavne, Israel.
  • Schmidt M; Department of Biomedical Engineering, Faculty of Engineering, Tel Aviv University, Tel Aviv, Israel.
  • Deutsch L; Unit of Nuclear Engineering, Faculty of Engineering Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Den RB; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel.
  • Kelson I; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel.
  • Keisari Y; Physics Laboratory, Alpha Tau Medical, Jerusalem, Israel.
  • Arazi L; Biostatistics Department, BioStats Statistical Consulting Ltd., Maccabim, Israel.
  • Cooks T; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel.
  • Domankevich V; Department of Radiation Oncology, Urology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States.
Front Oncol ; 12: 888100, 2022.
Article en En | MEDLINE | ID: mdl-36237307

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Israel

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Israel